Rocky Mountain Cancer Centers - Denver Midtown — Denver, Colorado

Rocky Mountain Cancer Centers - Denver Midtown is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers - Denver Midtown has participated in 7 clinical trials with 1 currently active.

Therapeutic areas: Colorectal Cancer Stage II, Colorectal Cancer Stage III, Leukemia.

Sponsors: BioNTech SE, University of Texas Southwestern Medical Center, Oncotherapeutics.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers - Denver Midtown?

Rocky Mountain Cancer Centers - Denver Midtown has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers - Denver Midtown conducted?

Rocky Mountain Cancer Centers - Denver Midtown has 7 clinical trials on record, with 1 currently active. Their work covers Colorectal Cancer Stage II, Colorectal Cancer Stage III, Leukemia.

Is Rocky Mountain Cancer Centers - Denver Midtown accredited by Crixeo Health?

Yes — Rocky Mountain Cancer Centers - Denver Midtown holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rocky Mountain Cancer Centers - Denver Midtown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.